E08.3511 Diab with prolif diabetic rtnop with macular edema, r eye

Instructional Notes:

E08.3511
Description: Diab with prolif diabetic rtnop with macular edema, r eye
↓
E08.351
Description: Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with macular edema
↓
E08.35
Description: Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy
↓
E08.3
Description: Diabetes mellitus due to underlying condition with ophthalmic complications
↓
E08
Description: Diabetes mellitus due to underlying condition
Exclude1:
- drug or chemical induced diabetes mellitus (E09.-)
- gestational diabetes (O24.4-)
- neonatal diabetes mellitus (P70.2)
- postpancreatectomy diabetes mellitus (E13.-)
- postprocedural diabetes mellitus (E13.-)
- secondary diabetes mellitus NEC (E13.-)
- type 1 diabetes mellitus (E10.-)
- type 2 diabetes mellitus (E11.-)
Code First:
- the underlying condition, such as:
- congenital rubella (P35.0)
- Cushing's syndrome (E24.-)
- cystic fibrosis (E84.-)
- malignant neoplasm (C00-C96)
- malnutrition (E40-E46)
- pancreatitis and other diseases of the pancreas (K85-K86.-)
Use Additional Code:
- code to identify control using:
- injectable non-insulin antidiabetic drugs (Z79.85)
- insulin (Z79.4)
- oral antidiabetic drugs (Z79.84)
- oral hypoglycemic drugs (Z79.84)
↓
E08-E13
Description: Diabetes mellitus (E08-E13)
↓
E00-E89
Description: Endocrine, nutritional and metabolic diseases
Exclude1:
- transitory endocrine and metabolic disorders specific to newborn (P70-P74)
Notes:
- All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.